NCT07525089 is a NA clinical trial of BM111 in VRE Colonization, sponsored by BioMe Inc..

Who is sponsoring NCT07525089?

NCT07525089 is sponsored by BioMe Inc..

What drugs are being tested in NCT07525089?

Interventions in NCT07525089: BM111, Placebo.

What condition does NCT07525089 study?

NCT07525089 studies VRE Colonization, CRE Colonization.

Is NCT07525089 still recruiting?

NCT07525089 is currently enrolling by invitation. Last updated 13 April 2026.

Last reviewed 2026-04-13 · How we verify

NCT07525089

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Human Clinical Trial to Evaluate the Decolonization Efficacy of BM111 Against Carbapenem-Resistant Enterobacteriaceae (CRE) and Vancomycin-Resistant Enterococcus (VRE)

ENROLLING BY INVITATION NA Last updated 13 April 2026

What this trial tests

NA trial testing BM111 in VRE Colonization in 38 participants. Enrolling by invitation.

Timeline

23 March 2026

Primary endpoint
30 October 2026

20 February 2027

Quick facts

Lead sponsor	BioMe Inc.
Phase	NA
Status	ENROLLING BY INVITATION
Study type	INTERVENTIONAL
Allocation	randomized
Design	single group
Masking	quadruple
Primary purpose	treatment
Enrollment	38
Start date	23 March 2026
Primary completion	30 October 2026
Estimated completion	20 February 2027
Sites	1 location across South Korea

Drugs / interventions tested

BM111
Placebo

Conditions studied

VRE Colonization — all drugs for VRE Colonization →
CRE Colonization — all drugs for CRE Colonization →

Sponsor

BioMe Inc.

Who can join

Adults 19 to 65, any sex, with VRE Colonization or CRE Colonization. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A clinical study to eliminate intestinal colonization in subjects harboring microorganisms resistant to carbapenem and vancomycin antibiotics, thereby treating infections caused by these microorganisms.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07525089 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by BioMe Inc.
Last refreshed: 13 April 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07525089.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing